Navigation Links
Labor Union Coalition Alerts Industry Analysts About Rite Aid
Date:11/6/2007

ical sector. This week, thousands of Taft-Hartley and union health and pension fund trustees and administrators are in Anaheim, California, for the annual International Foundation of Employee Benefit Plans conference. This conference is considered a premier marketing opportunity for health and investment management vendors, and Rite Aid Health Solutions will be there along with Caremark, Medco and other PBMs competing for billions of dollars in union business.

Among conference participants, Rite Aid is sure to tout itself as a union- friendly company. However, our unions will be there in force to set the record straight on the company's recent assaults on workers' rights. For months, Rite Aid has failed to comply with legally-binding contractual language governing the rights of workers in newly acquired stores and has waged a union-avoidance campaign in California among warehouse workers seeking representation through the International Longshore and Warehouse Union (ILWU).

To get the word out about Rite Aid's recent anti-union actions, SEIU, UFCW and ILWU welcomed hundreds of trustees at a reception on the conference's opening night. Throughout the week, we are distributing information and encouraging union trustees and administrators to question Rite Aid's actions and encourage them to not do business with the company until it starts doing right by its workers.

Today, Rite Aid is at a critical juncture. The company's future is riding on the success of the acquisition, the growth of its PBM business, emergence from the scandals that plagued the company in the past, and improving same store sales during the upcoming holiday season. Rite Aid is already on thin ice; it can ill-afford to put it all at risk by antagonizing its workforce.

We are fully committed to upholding the legally-binding contractual rights of Rite Aid and Eckerd Brooks workers and will not stop until we are satisfied that Rite Aid is on the right track for its workers, and in
'/>"/>

SOURCE 1199SEIU; UFCW; ILWU
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Health care incentive model offers collaborative approach
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
4. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
5. Laboratory at UI plays major role in diagnosing cancer
6. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Recovery Resources Collaborates with Two Nonprofit Agencies for Children of Alcoholics Outreach Program
9. MU researchers to collaborate on $20 million project
10. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
11. American Red Cross and FedEx Announce Collaboration to Help Small Businesses Get Prepared for Disaster
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... day lead to a novel technique to combat cancer, s...hDay News) -- Belgian researchers have discovered ...sugar for food, and this might lead to new treatme...ive and proliferate, all cells in the body need to...ucose], a process that requires oxygen. Compared w...
(Date:11/21/2008)..., Nov. 21 New research ... a smokeless, spitless tobacco product aimed at yo...e found that RJ Reynolds, Camel Snus - touted as a...ntains surprisingly high levels of nicotine. , ... other snuff products," said Bruce Adkins of the s...
(Date:11/21/2008)...s Intend To Vigorously Protect Investment And Rest...21 Dr. Stephen Joffe, C...nt to their Schedule 13D with the U.S. Securities ...ed a 13D disclosing ownership of 11.4% of LCA-Visi...kPlus fixed-site laser vision correction centers i...
(Date:11/21/2008)... The general membership of the Med...ee new individuals at their Annual,Awards Dinner ...n New York. A,Lifetime Achievement Award will als...edical Advertising Hall of Fame are: , Ronald P...account position,at Sudler & Hennessey. In 19...
Breaking Medicine News(10 mins):Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3
...vegetables may be what you need say researchers. I...ioxidants in fruits and vegetables which may redu...ype of stroke caused when blood clots cut off oxyg...the antioxidants found in fruits and vegetables. F...
...regenerate following exercise or injury and harbor...plish the job: satellite cells and adult stem cell...cells. A certain group of these stem cells is invo...nto the muscle cell development pathway by injury....
...people will be diagnosed with kidney cancer. About...n earlier and more// accurate diagnosis. Mike Froz...ncer. Currently, the only way to detect kidney can...y scan or magnetic resonance imaging, but Frozzitt...
...ted States each year. On average, men who smoke sh.../ who smoke cut their life expectancy by about 15 ...king. In 1964, the Surgeon General’s Report showe...ung and larynx in men and chronic bronchitis in bo...
Other Medicine News:Health News:Regeneration of muscle 2Health News:Urine Test for Kidney Cancer 2
(Date:11/20/2008)...ewswire/ -- Milk. It does a body good. And,now it...fter years of,research, scientists at OncoNutriti...lk that stimulate the body,s own production of ant...s Release, go to:, http://www.prnewswire.com/mnr/e...ew cancer therapies, the chief scientist, Dr. Davi...
(Date:11/20/2008)...-- Clinical data from a prospective,registry pres... shows DVT,treatment with the Trellis(R) Peripher...anta Clara, CA) successfully breaks up the blood c... This technique, called isolated pharmacomechanic... and safely than current catheter-directed thrombo...
(Date:11/19/2008)... Amgen,(Nasdaq: AMGN )...bsidiary of,Takeda Pharmaceutical Company Limited...the Phase 3 MONET1 trial evaluating motesanib (AMG...tin for the first-line treatment of,advanced non-...y suspended,following a planned safety data revie...
(Date:11/19/2008)...re/ -- Isogen, a contract development and,manufac...ounced the first,phase launch of its contract fac...ally address the process, facility and capacity pr...ghly-niched, low-volume clinical and,early-stage ... Companies can invest over $100 million and four ...
Breaking Medicine Technology:Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Isogen Launches Major New Facility to Address Global Biopharma Demand 2BioMarin Announces First Quarter 2008 Financial Results 4955 1BioMarin Announces First Quarter 2008 Financial Results 4955 2BioMarin Announces First Quarter 2008 Financial Results 4955 3BioMarin Announces First Quarter 2008 Financial Results 4955 4BioMarin Announces First Quarter 2008 Financial Results 4955 5BioMarin Announces First Quarter 2008 Financial Results 4955 6BioMarin Announces First Quarter 2008 Financial Results 4955 7BioMarin Announces First Quarter 2008 Financial Results 4955 8BioMarin Announces First Quarter 2008 Financial Results 4955 9BioMarin Announces First Quarter 2008 Financial Results 4955 10BioMarin Announces First Quarter 2008 Financial Results 4955 11Nephros Appoints Gerald J Kochanski as Chief Financial Officer 4951 1Nephros Appoints Gerald J Kochanski as Chief Financial Officer 4951 2Nephros Appoints Gerald J Kochanski as Chief Financial Officer 4951 3Nephros Appoints Gerald J Kochanski as Chief Financial Officer 4951 4Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases 1932 1Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases 1932 2Engineers harness cell phone technology for use in medical imaging 4950 1Engineers harness cell phone technology for use in medical imaging 4950 2Engineers harness cell phone technology for use in medical imaging 4950 3Engineers harness cell phone technology for use in medical imaging 4950 4
... THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Apr 30, 2...esults from a pivotal Phase 3,trial which showed t...clonal antibody directed against the epidermal gro...free survival (PFS) compared,to best supportive ca...who had failed fluoropyrimidine, irinotecan, and,o...
... ROCHESTER, N.Y., May 02, 2007 /PRNewswire/ -- A ... before last winter may have been,less effective t...adults who had flu shots before last winter were o...se who were not vaccinated. The,differences were l...ic.(1) In the winters of 2003/2004 and 2004/2005 a...
Other Medicine Technology:Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 2Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 3Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 4Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 5Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 6Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 2Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 3Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 4Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 5Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 6
It provides excellent illumination from an inexpensive platform and is mounted on the comfortable UltraLite headband.
A rapid rise in intracranial pressure requires early recognition, intervention and continuous monitoring. Ventrix utilizes state-of-the-art fiberoptic technology that gets to the source of pressure.
The Codman ICP Monitoring System provides highly accurate measurements of intracranial pressure at the source-subdural, parenchymal or intraventricular levels. The information is relayed electronical
Slightly curved blunt dissector, double-ended. Length 11 1/2" (272 mm)
Medicine Products: